The Atlantic Diabetes in Pregnancy (DIP) initiative was established in 2005 with funding from the Health Research Board of Ireland. It is a joint venture involving hospitals within the Saolta Hospital Group and the National University of Ireland Galway. Its primary aim is to engage in high quality research and use this information to develop a bespoke service for women with diabetes before, during and after pregnancy. The ultimate goal is to ensure that pregnancy outcomes for women with diabetes are equal to those without diabetes.
We currently provide pre-pregnancy, natal and post-natal care to women with diabetes at participating hospitals along the Irish Atlantic Seaboard. Research themes include screening, treatment and outcomes of gestational diabetes and optimal management of pre-gestational diabetes before and during pregnancy.
News and Updates
Calling all researchers, women, health professionals! We need your help! Please assist Atlantic DIP Researchers and collaborators in a very important piece of research which aims to develop a core outcome set for women with previous gestational diabetes. Simply copy-paste the following link to get more information and take a quick online survey. No prior experience or medical knowledge needed! http://app.surveymethods.com/EndUser.aspx?E4D2ACB3E4A6B8B4E5A1B0
Today is: World Diabetes Day 2017 The theme of World Diabetes Day 2017 is Women and diabetes – our right to a healthy future. https://www.idf.org/our-activities/world-diabetes-day/wdd-2017.html • 1 in 7 births is affected by gestational diabetes. In the Saolta Region, your midwife or doctor will tell you if you need to be tested for diabetes in your pregnancy. • If you have type 1 or type 2 diabetes, it is very important that you plan for your pregnancy. To view or download our prepregnancy care leaflet please click here. The Diabetes in Pregnancy Service for the Saolta Region will be glad to be of assistance to you. Clinics are available throughout…
Two new research trials that may be of interest to you that we are involved in. EMERGE for women with GDM examining the benefits of Metformin and EXPECT for women with Type 1 Diabetes examining a new insulin Degludec in pregnancy preparation or in pregnancy. Call Michelle (086 0208726) for further information.
Like us on Facebook
Follow us on Twitter